PMID- 10068673 OWN - NLM STAT- MEDLINE DCOM- 19990330 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 93 IP - 6 DP - 1999 Mar 15 TI - Involvement of wiskott-aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. PG - 2003-12 AB - Bruton's tyrosine kinase (Btk) has been shown to play a role in normal B-lymphocyte development. Defective expression of Btk leads to human and murine immunodeficiencies. However, the exact role of Btk in the cytoplasmic signal transduction in B cells is still unclear. This study represents a search for the substrate for Btk in vivo. We identified one of the major phosphoproteins associated with Btk in the preB cell line NALM6 as the Wiskott-Aldrich syndrome protein (WASP), the gene product responsible for Wiskott-Aldrich syndrome, which is another hereditary immunodeficiency with distinct abnormalities in hematopoietic cells. We demonstrated that WASP was transiently tyrosine-phosphorylated after B-cell antigen receptor cross-linking on B cells, suggesting that WASP is located downstream of cytoplasmic tyrosine kinases. An in vivo reconstitution system demonstrated that WASP is physically associated with Btk and can serve as the substrate for Btk. A protein binding assay suggested that the tyrosine-phosphorylation of WASP alters the association between WASP and a cellular protein. Furthermore, identification of the phosphorylation site of WASP in reconstituted cells allowed us to evaluate the catalytic specificity of Btk, the exact nature of which is still unknown. FAU - Baba, Y AU - Baba Y AD - Department of Medicine III, Osaka University Medical School, Osaka, Japan. FAU - Nonoyama, S AU - Nonoyama S FAU - Matsushita, M AU - Matsushita M FAU - Yamadori, T AU - Yamadori T FAU - Hashimoto, S AU - Hashimoto S FAU - Imai, K AU - Imai K FAU - Arai, S AU - Arai S FAU - Kunikata, T AU - Kunikata T FAU - Kurimoto, M AU - Kurimoto M FAU - Kurosaki, T AU - Kurosaki T FAU - Ochs, H D AU - Ochs HD FAU - Yata, J i AU - Yata Ji FAU - Kishimoto, T AU - Kishimoto T FAU - Tsukada, S AU - Tsukada S LA - eng GR - HD17427/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Cross-Linking Reagents) RN - 0 (Proteins) RN - 0 (Receptors, Antigen, B-Cell) RN - 0 (WAS protein, human) RN - 0 (Wiskott-Aldrich Syndrome Protein) RN - 21820-51-9 (Phosphotyrosine) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.2 (Agammaglobulinaemia Tyrosine Kinase) RN - EC 2.7.10.2 (BTK protein, human) SB - AIM SB - IM MH - Agammaglobulinaemia Tyrosine Kinase MH - Amino Acid Sequence MH - Animals MH - B-Lymphocytes/*enzymology MH - Binding Sites MH - Burkitt Lymphoma MH - Cross-Linking Reagents MH - Cytoplasm/enzymology MH - Humans MH - Mutagenesis, Site-Directed MH - Phosphorylation MH - Phosphotyrosine/metabolism MH - Protein-Tyrosine Kinases/chemistry/genetics/*metabolism MH - Proteins/chemistry/genetics/*metabolism MH - Receptors, Antigen, B-Cell/metabolism MH - Structure-Activity Relationship MH - Transfection MH - Tumor Cells, Cultured MH - Wiskott-Aldrich Syndrome Protein EDAT- 1999/03/09 00:00 MHDA- 1999/03/09 00:01 CRDT- 1999/03/09 00:00 PHST- 1999/03/09 00:00 [pubmed] PHST- 1999/03/09 00:01 [medline] PHST- 1999/03/09 00:00 [entrez] AID - S0006-4971(20)48675-6 [pii] PST - ppublish SO - Blood. 1999 Mar 15;93(6):2003-12.